Transcription factors in HIV-1 infection.

Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Transcription factors in HIV-1 infection.

Annu Conf Australas Soc HIV Med. 1993 Oct 28-30;5:105 (poster no. 61). Unique Identifier : AIDSLINE ASHM5/94348921
Kedar P; Arden KE; Todd BJ; Pope JH; NCHVR, Royal Children's Hospital, Brisbane, Qld.

Abstract: Transcriptional regulation involves the interaction of enhancer-promoter regions with cellular binding proteins. NF-kB is a nuclear transcriptional factor which binds and mediates transcription from the sequences in the promoter region. In our system we have studied NF-kB and related proteins in PHA stimulated cord blood mononuclear cells. In this model the cells were treated with rIL2 and with or without DEAE-dextran, and nuclear extracts were made. Binding of NF-kB enhancer region sequences with these extracts were studied by gel shift assays. As well as NF-kB, another protein NF-TIM was detected in large amounts. This NF-TIM also binds to NF-kB region even when it is mutated (GGG to CTC) but binding is decreased with double mutated enhancer (GGG to CTC and CCG to AAC). Further studies of the role of NF-TIM in HIV-1 replication are in progress with UV crosslinking, footprinting, and cloning of enhancer region and its mutants in a reporter gene system.

Keywords: Cell Line Human HIV Enhancer/GENETICS HIV Infections/*MICROBIOLOGY HIV-1/*GENETICS Monocytes/MICROBIOLOGY Mutation/GENETICS NF-kappa B/GENETICS Transcription Factors/*GENETICS Virus Replication/*GENETICS ABSTRACT
941230
M94C4306

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .